banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
Nilotinib CAS 641571-10-0

Nilotinib CAS 641571-10-0

CAS TSIS TAU: 641571-10-0
Cov Qauv Nqaij: C28H22F3N7O
Cov Nqa Molecular: 529.516
EINECS TSIS MUAJ: 700-544-5
MDL TSIS TAU: MFCD09833716

Txhawb tshuaj

Khoom Qhia:

Khoom npe: nilotinib CAS TSIS: 641571-10-0

Txhais:

Nilotinib (AMN-107);

nws cov intermediates;

Nilotinib rau kev tshawb nrhiav;

Tshuaj& Cov Khoom Uas Lub Cev:

Zog: Off-Dawb Khoom

Ntsuas: ≥99.0%

Qhov ceev: 1.36 g / cm3

Qhov nqe lus txhawb siab: 1.65

Chaw Cia Lub Sij Hawm.:-20℃ Lub Freezer

Melting point: 231-233 ℃

Cov Ntaub Ntawv Kev Nyab Xeeb:

Cov Chav Kawm Kom Nyab Xeeb: 6.1 (b)

Cov Pab Pawg: III

RIDADR: 2206

Nilotinib (AMN107, lub npe lag luam Tasigna), nyob rau hauv daim ntawv ntawm hydrochloride monohydrate ntsev, yog me-molecule tyrosine kinase inhibitor pom zoo rau kev kho mob ntawm imatinib-resistant mob myelogenous leukemia. Cov txheej txheem ntsig txog imatinib, nws tau tsim raws tus qauv ntawm Abl-imatinib txoj hauv kev los daws qhov teeb meem imatinib tsis raug thiab tsis kam. Nilotinib yog kev xaiv Bcr-Abl kinase inhibitor uas yog 10-30 quav ntau zog dua li imatinib hauv kev ua kom cov tshuaj Bcr-Abl tyrosine kinase kev ua haujlwm thiab kev loj hlob ntawm Bcr-Abl tshaj tawm cov hlwb.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.


Cim npe nrov: nilotinib cas 641571-10-0, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

Xa kev nug